Supplemental Tables 1-2 from Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma
Authors:
- Crescens TiuCTCrescens Tiu
- Wing YauWYWing Yau
- Diogo SilvaDSDiogo Silva
- Nick WaldronNWNick Waldron
- Malaka AmeratungaMAMalaka Ameratunga
- Mariana ScarantiMSMariana Scaranti
- Andrea BiondoABAndrea Biondo
- Liam WelshLWLiam Welsh
- Antonia CreakACAntonia Creak
- Timothy L. JonesTJTimothy L. Jones
- Andrew J. MartinAMAndrew J. Martin
- Leslie BridgesLBLeslie Bridges
Open Access
- 3 August 2026
- other
- Published by American Association for Cancer Research (AACR)